These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1910438)

  • 1. Nonleast-squares jackknife regression in drug design.
    Mager PP
    Drug Des Deliv; 1991 Apr; 7(2):119-29. PubMed ID: 1910438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
    Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
    Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
    Cormanich RA; Goodarzi M; Freitas MP
    Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
    Du QS; Huang RB; Wei YT; Du LQ; Chou KC
    J Comput Chem; 2008 Jan; 29(2):211-9. PubMed ID: 17559075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods.
    Hoffman B; Cho SJ; Zheng W; Wyrick S; Nichols DE; Mailman RB; Tropsha A
    J Med Chem; 1999 Aug; 42(17):3217-26. PubMed ID: 10464009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
    Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
    J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust QSAR models using Bayesian regularized neural networks.
    Burden FR; Winkler DA
    J Med Chem; 1999 Aug; 42(16):3183-7. PubMed ID: 10447964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-based design: formalism and application of receptor-dependent RD-4D-QSAR analysis to a set of glucose analogue inhibitors of glycogen phosphorylase.
    Pan D; Tseng Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(5):1591-607. PubMed ID: 14502494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico human and rat Vss quantitative structure-activity relationship models.
    Gleeson MP; Waters NJ; Paine SW; Davis AM
    J Med Chem; 2006 Mar; 49(6):1953-63. PubMed ID: 16539383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying data mining techniques to library design, lead generation and lead optimization.
    Weaver DC
    Curr Opin Chem Biol; 2004 Jun; 8(3):264-70. PubMed ID: 15183324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks.
    So SS; Karplus M
    J Med Chem; 1996 Mar; 39(7):1521-30. PubMed ID: 8691483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists.
    Froimowitz M; Cody V
    Drug Des Discov; 1997 Aug; 15(2):63-81. PubMed ID: 9342550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical modeling of a ligand knowledge base.
    Mansson RA; Welsh AH; Fey N; Orpen AG
    J Chem Inf Model; 2006; 46(6):2591-600. PubMed ID: 17125199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational approach to botanical drug design by modeling quantitative composition-activity relationship.
    Wang Y; Wang X; Cheng Y
    Chem Biol Drug Des; 2006 Sep; 68(3):166-72. PubMed ID: 17062014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general method for exploiting QSAR models in lead optimization.
    Lewis RA
    J Med Chem; 2005 Mar; 48(5):1638-48. PubMed ID: 15743205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR design of novel antiepileptic sulfamides.
    Gavernet L; Dominguez Cabrera MJ; Bruno-Blanch LE; Estiú GL
    Bioorg Med Chem; 2007 Feb; 15(3):1556-67. PubMed ID: 17158052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors.
    Roy K; Roy PP
    Chem Biol Drug Des; 2008 Nov; 72(5):370-82. PubMed ID: 19012573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of QSAR in design of antiinflammatory arylalkanoic acids.
    Kuchar M; Rejholec V; Grimová J
    Prog Clin Biol Res; 1989; 291():357-60. PubMed ID: 2726873
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of fungicidal activities of rice blast disease based on least-squares support vector machines and project pursuit regression.
    Du H; Wang J; Hu Z; Yao X; Zhang X
    J Agric Food Chem; 2008 Nov; 56(22):10785-92. PubMed ID: 18950187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.